Detalhe da pesquisa
1.
Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational study.
J Peripher Nerv Syst
; 29(1): 38-46, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311337
2.
Expression of CD44 is associated with aggressiveness in seminomas.
Mol Biol Rep
; 51(1): 693, 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38796656
3.
Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway.
Am J Physiol Cell Physiol
; 325(3): C708-C720, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37575061
4.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945632
5.
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients.
J Peripher Nerv Syst
; 27(2): 166-174, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384143
6.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416053
7.
Prospective assessment of psychopathological symptoms and their relation to demographic factors in primary caregivers of cancer patients throughout chemotherapy.
Support Care Cancer
; 30(3): 2467-2475, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779919
8.
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study.
Support Care Cancer
; 30(2): 1807-1814, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599664
9.
Isolated optic neuritis after pembrolizumab administration for non-small-cell lung carcinoma.
Int J Neurosci
; 132(7): 643-648, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998608
10.
Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity.
J Peripher Nerv Syst
; 26(1): 43-48, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345432
11.
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.
Br J Cancer
; 123(3): 355-361, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488135
12.
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer.
Oncologist
; 25(10): 853-858, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272489
13.
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding.
Rheumatology (Oxford)
; 59(5): 1041-1050, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344435
14.
Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.
J Peripher Nerv Syst
; 25(2): 178-183, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277545
15.
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.
J Peripher Nerv Syst
; 25(2): 171-177, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166812
16.
Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity.
Support Care Cancer
; 28(4): 1991-1995, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378844
17.
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.
Int J Mol Sci
; 21(9)2020 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32403289
18.
Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer.
Int J Mol Sci
; 21(11)2020 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466535
19.
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
Oncologist
; 24(4): 491-497, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867244
20.
Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
J Peripher Nerv Syst
; 24(4): 298-303, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486252